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Objectives. We aimed to determine the relationship between insulin resistance and serum 25-hydroxyvitamin D (25-OHD) levels
inobesechildrenandtheirnonobesepeers.Materials and Methods.Includedinthestudygroupwere188obesechildren(aged9–15
years),and68age-andgender-matchedhealthychildrenofnormalweightascontrolgroup.Anthropomorphicdatawerecollected
on patients and fasting serum glucose, insulin, serum lipids, alanine aminotransaminase (ALT) and 25-OHD were measured. The
homeostatic model assessment of insulin resistance (HOMA-IR) was calculated in both groups. Results.Th el e v e l so f2 5 - O H Di n
theobesegroupweresignificantlylowerthanthoseofthenonobese(𝑃 = 0.002).HOMA-IR,triglycerides,low-densitylipoprotein,
and ALT levels in the obese group were significantly higher than values of control group (𝑃 < 0.001 and 𝑃 = 0.002,r e s p . ) .I nt h e
obese group, vitamin D deficiency, insufficiency, and sufficiency (25-OHD < 10ng/dl, < 20, >10ng/dl; > 20ng/dl, resp.) were not
correlated with HOMA-IR (𝑟 : −0.008, 𝑃 = 0.935). HOMA-IR was negatively correlated with BMI, BMI SDS, and BMI%, and
triglycerides, low-density lipoprotein, and ALT levels (𝑃 < 0.001). Conclusion.Th ei n s u l i nr e s i s t a n c eo ft h eo b e s es u b j e c t sw h o
were vitamin D deficient and insufficient did not statistically differ from those with vitamin D sufficiency. Low 25-hydroxyvitamin
D levels were not related with higher insulin resistance in obese children and adolescents. In obese subjects, insulin resistance was
affected more from BMI, BMI SDS, and BMI% than from 25-hydroxyvitamin D levels.
1. Introduction
Vitamin D deficiency, a pandemic health problem, is a major
cause of rickets in infants and toddlers and of osteope-
nia in adolescents [1–6]. The production of vitamin D
in the skin depends on sunshine exposure, latitude, skin-
coveringclothes,theuseofsunblock,andskinpigmentation.
Although the Mediterranean region generally has a sunny
climate, higher rates of hypovitaminosis D are seen in
European and Mediterranean countries [7–10]. Vitamin D
deficiencyisespeciallycommonintheMiddleEastbecauseof
the prevalence of wearing skin-covering clothes and because
of staying out of the sun [11].
Besides acting as a regulatory hormone in calcium
metabolism, noncalciotropic effects of vitamin D such as
cellular differentiation and replication in many organs have
been found. Vitamin D is also critical in glucose homeostasis
and insulin secretion via its endocrine mechanisms [12–14],
besides itsautocrineandparacrineroleinadipocytes [15,16].
Insulin resistance plays a major role in obesity, and as a
population gets heavier at younger ages, the age of onset of
non-insulin-dependent diabetes mellitus also decreases [17].
Regrettably, obesity and adiposity is an emerging trend in
the industrialized world it is a result of alimited exercise, a
sedentary lifestyle, and replete diets with high-calorie, low-
nutrient foods.
The literature provides conflicting data as to whether
vitamin D deficiency and insufficiency is a risk factor for
the development of impaired glucose tolerance in childhood
obesity [18]. Low 25-hydroxyvitamin D level is found to be
associated with insulin resistance in adults [19], but no rela-
tionship was found with parameters of glucose homeostasis
and insulin sensitivity in healthy youth [20]. This study was
conducted to study the relationship of vitamin D deficiency2 International Journal of Endocrinology
and insufficiency with insulin resistance in obese children
and adolescents and the prevalence of vitamin D deficiency
among children living in the metropolitan area of Istanbul,
Turkey.
2. Materials and Methods
Enrolled in the study were 118 obese children (50% males,
50% females; mean age 12±2.2 years) and a control group of
68 healthy nonobese children (48.5% males, 51.5% females;
mean age 12.6 ± 1.7 y e a r s ) .Th e yh a db e e na d m i t t e dt ot h e
Bezmialem Vakif University General Pediatrics Clinic in the
Marmara region between January 2011 and January 2012.
Each participant underwent a detailed physical exami-
nation (including evaluation for syndromes and endocrine
diseases), as well as a laboratory evaluation. Standing height
was measured to the nearest 0.1cm with a Harpenden fixed
stadiometer. Body weight (kg) was measured on a SECA
balance scale to the nearest 0.1kg, with each subject dressed
in a light T-shirt and shorts. Body mass index (BMI) was
calculated by dividing weight by height (kg/m
2). Obesity
was defined as the BMI > 97th percentile, the definition of
t h eI n t e r n a t i o n a lT a s kF o r c eo fO b e s i t yi nC h i l d h o o da n d
Population-Specific Data [21, 22]. Waist circumference was
measured between the xiphoid process and iliac crest. Chil-
dren whose obesity was the result of a syndromal problem
(Prader Willi, Laurence-Moon Biedl syndrome, etc.) were
e x c l u d e d ,a sw e r et h o s ew h o s eo b e s i t yh a da ne n d o c r i n a l
cause such as Cushing’s Syndrome or hypothyroidism. None
of the participants was using meneedication or had a history
or evidence of current metabolic, cardiovascular, respiratory,
or hepatic disease. Patients taking vitamin and/or mineral
supplements were excluded.
All blood analyses were performed on fasting samples
in both the study and control groups. Cholesterol, high-
density lipoprotein (HDL), low-density lipoprotein (LDL),
and triglycerides were measured by the homogeneus col-
orimetric enzyme technique (Roche, Cobas 8000). Serum
25-OHD levels were determined by the electrochemilumi-
nescence enzyme immunoassay method (ECLIA) (ADVIA
Centaur, USADPC Co., USA). Glucose was measured by
the glucose oxidase technique (Siemens ADVIA 1800) and
i n s u l i nl e v e l sw e r ea n a l y z e dw i t hd i r e c tc h e m i l u m i n e s c e n c e
technique (Siemens centaur, USA). Insulin resistance was
estimated from fasting plasma measurements using HOMA-
IR (insulin (mU/L) × glucose (mmol/L)/22.5) [23]. Insulin
resistance criteria were HOMA-IR >2.5 for prepubertal
children and HOMA-IR >4.0 for adolescents [24]. Vitamin
D status was classified as either deficient, insufficient, or
sufficient (serum 25-OHD: <10ng/mL, 10–20ng/mL, and
>20ng/mL, resp.) [25].
Statistical analysis was performed with PASW Statistics,
v.13.0. A paired 𝑡-test was used to calculate the difference
of two parameters in groups; one-way ANOVA was used
in the calculation of difference of two parameters in groups
with more than two in the same group and between different
groups. Multiple comparisons were done with the Pearson
Table1:Meananthropometricdataofthestudyandcontrolgroups.
Obese
(𝑛 = 118)
Nonobese
(𝑛=6 8 )
𝑃
Male/female 59/59 33/35 0.839
Age (years ± SD) 12 ± 2.2 12.6 ± 1.7 0.79
Waist circumference (cm) 87.1 ± 10.6 68.2 ± 14.7 0.027
BMI (kg/m
2) 29.6 ± 3.9 20.1 ± 3 <0.001
BMI SDS 2.1 ± 0.2 0.15 ± 1 <0.001
BMI% 97.8 ± 1.1 54 ± 29.3 <0.001
SD: standard deviation, BMI: body mass index, BMI SDS: body mass index
standard deviation score, BMI%: body mass index percentage.
Table 2: Metabolic markers of the study and control groups.
Obese group
(𝑛 = 118)
Nonobese
group (𝑛=6 8 )
𝑃
Glucose (mg/dL) 91.2 ± 10.5 89.1 ± 10.4 0.18
Insulin (𝜇U/mL) 17.4 ± 10.2 14.1 ± 8.3 0.024
HOMA-IR 3.9 ± 2.5 3.1 ± 2.2 <0.001
25-OHD (ng/dL) 14.4 ± 8.1 18.6 ± 9.5 0.002
ALT (U/L) 25.8 ± 15.8 17.2 ± 13.2 0.002
Triglyceride (mg/dL) 112.7 ± 52.4 86.1 ± 40.7 0.002
LDL cholesterol (mg/dL) 103.2 ± 26.4 90.6 ± 22.9 0.010
HDL cholesterol (mg/dL) 49.4 ± 14 54.7 ± 14.5 0.034
Total cholesterol (mg/dL) 168.1 ± 30.7 160 ± 25.2 0.095
HOMA-IR:homeostaticmodelassessmentofinsulinresistance,25-OHD:25
hydroxyvitamin D.
correlation. Categorical data were evaluated using the Chi-
square test; 𝑃 < 0.05 was accepted as statistically significant.
The study was approved by the local ethical committee.
Written informed consent was obtained from parents.
3. Results
Age and gender distribution were not statistically different
between the two groups (𝑃 = 0.79 a n d0 . 8 3 9 ,r e s p . ) .
Subjects of the obese group had significantly higher waist
circumference SDS (0.027), BMI (𝑃 < 0.001), BMI SDS (𝑃>
0.001), and BMI percentage (𝑃 > 0.001)c o m p a r e dw i t ht h e
control group (Table 1).
Table 2 presents the biochemical characteristics of all
subjects. Compared with the nonobese subjects, obese sub-
jects had higher fasting insulin, HOMA-IR, serum ALT,
triglyceride, and total and LDL-cholesterol levels. The 25-
OHD levels of obese children were significantly lower than
those of the non-obese (𝑃 = 0.002). HDL-cholesterol levels
of the obese subjects were significantly lower than the non-
obese ones.
The obese group was classified according to 25-OHD
levels as vitamin D deficient (≤10ng/mL), insufficient (10–
20ng/mL), and sufficient (25-OHD > 20ng/dL) [26]. The
groups were similar in age and gender ratio. The correlation
of vitamin D levels with insulin resistance in the obese group
was evaluated with HOMA-IR. The HOMA-IR levels of theInternational Journal of Endocrinology 3
Table 3: The correlation of HOMA-IR and vitamin D levels in obese group
∗.
25-OHD level (ng/dL) <10 (𝑛=3 9 )1 0 – 2 0 ( 𝑛=4 3 ) >20 (𝑛=3 1 ) 𝑃
Male/female 19/20 22/21 16/15 >0.05
BMI 29.3 ± 3.4 29.3 ± 3.9 28.4 ± 4.2 >0.05
BMI SDS 2 ± 0.2 2 ± 0.2 2 ± 0.2 >0.05
HOMA-IR (mean ± SD) 3.9 ± 2.4 3.5 ± 2 3.8 ± 2.7 0.72
∗One-way ANOVA test was used for correlation analysis.
Table 4: Bivariate correlations between covariates among HOMA-IR in the obese group.
HOMA-IR
Age
(𝑛 = 118)
25-OHD
(𝑛 = 112)
BMI
(𝑛 = 115)
BMI SDS
(𝑛 = 115)
BMI%
(𝑛 = 115)
Triglycerides
(𝑛 = 115)
LDL
(𝑛 = 114)
HDL
(𝑛 = 114)
∗∗𝑟 −0.041 −0.008 0.412 0.339 0.322 0.365 0.829 0.142
∗𝑃 0.664 0.935 <0.001 <0.001 <0.001 <0.001 <0.001 0.130
∗∗Correlation is significant at the 0.01 level (2 tailed).
∗Correlation is significant at the 0.05 level (2 tailed).
SDS: standard deviation score, BMI: body mass index, HOMA-IR: homeostatic model assessment of insulin resistance, 25-OHD: 25-hydroxyvitamin D level,
LDL: low-density lipoprotein, and HDL: high-density lipoprotein.
obese subjects who were vitamin D deficient and insuffi-
cient did not statistically differ from those with vitamin-D-
sufficient ones (𝑃 = 0.72)( Table 3).
Table 4 presents the correlations among HOMA-IR with
other biochemical parameters in the obese group. HOMA-
IR was not correlated significantly with age and serum 25-
OHD levels but significantly correlated with triglyceride and
LDLlevels.HOMA-IRcorrelatedsignificantlywithBMI(𝑃<
0.001),BMISDS(𝑃 < 0.01),andBMIpercentage(𝑃 < 0.001).
4. Discussion
Vitamin D deficiency and insufficiency are epidemic but
commonly undiagnosed among obese children. Obese chil-
dren in turn have higher risk of hypovitaminosis D. Turkey’s
vitamin D prophylaxis augmentation program (started in
2005) has resulted in a marked decrease in vitamin D
deficiency in healthy children under 1 year of age [26];
yet despite these improvements, most Turkish adolescents
are still vitamin D deficient. In our study, 25-OHD levels
were significantly lower in the obese group compared with
healthy subjects. This finding revealed that obesity could be
a risk factor of hypovitaminosis D in Turkish children and
adolescents.Recentstudiesfromdifferentcountrieshavealso
demonstrated that vitamin D deficiency is common in obese
children[27],possiblyduetothelowqualityofdiet[28].Here
in Turkey, rates of hypovitaminosis D in healthy adolescents
w e r e5 9 . 4 %a n d6 5 %i nt w od i ff e r e n ts t u d i e s[ 26, 29].
V itaminDplaysanimportantroleinglucosehomeostasis
in the mechanism of insulin release. Most of the studies
suggested vitamin D deficiency as a risk factor of disturbed
glucose homeostasis in adults [30–33], but this hypothesis is
still controversial in relation to children. It remains unclear
if vitamin D deficiency and insufficiency are associated with
insulin resistance in obese children and adolescents.
Insulin resistance was estimated from fasting plasma
measurements using HOMA-IR. In our study, insulin resis-
tance values were higher in obese subjects compared with
the healthy, vitamin-D-sufficient, age- and gender-matched
childrenandadolescents.Inordertodeterminetheroleof25-
hydroxyvitamin D levels in glucose intolerance and insulin
resistanceinobesechildren,wecomparetheHOMA-IRlevels
of vitamin-D-sufficient obese children and adolescents with
the vitamin-D-deficient and -insufficient obese ones. There
were no significant differences in HOMA-IR levels in obese
children and adolescents due to 25-hydroxyvitamin D levels.
In correlation analyses, we found that HOMA-IR depended
on the degree of obesity and correlated with serum lipid
profile. There was a significant trend towards higher insulin
concentrations and insulin resistance in subjects with higher
body mass index independent from 25-hydroxyvitamin D
levels.
Recent studies researching the relationship between vita-
min D deficiency and insulin resistance in obese children
revealed controversial results. In two studies, no relation-
ship was found between low vitamin D status and insulin
resistance [34, 35]. On the other hand, the literature mostly
supported the hypothesis that low vitamin D status is asso-
ciated with worse glucose tolerance. Kelly et al. [36]s h o w e d
that vitaminD deficiency is associated withincreasedinsulin
resistance in children. Alemzadeh et al. [37]o b s e r v e dap o s -
itive relationship between vitamin D status and insulin sen-
sitivity in children. The study by Reis et al. [16]s h o w e dt h a t
low serum vitamin D in adolescents was strongly associated
with increased risk for fasting hyperglycemia, hypertension,
andmetobolicsyndrome.InthestudyconductedbyGaranty-
Bogacka et al., fasting insulin levels and HOMA-IR were
f o u n dc o r r e l a t e dw i t hl o wv i t a m i nDl e v e l s[ 38].
A limitation of this study is that vitamin D deficiency
and insufficiency was defined only by 25-OHD levels. It
is 1,25-dihydroxyvitamin D which is active on the vitamin
D receptor in the insulin producing cells. It was also, not4 International Journal of Endocrinology
possible to evaluate other parameters modifying bone health
such as subjects’ dietary calcium intake or the responsiveness
of the vitamin D receptor. In addition, with the lack of
consensus regarding the definition of optimal vitamin D
status in children, it is not possible to determine the level
of vitamin D which disturbs glucose homeostasis and causes
metabolic effects.
I nc o n c l u s i o n ,i no u rs t u d y ,i n s u l i nr e s i s t a n c ec o r r e l a t e d
mostly with BMI but not with 25-hydroxyvitamin D levels
in the obese children and adolescents. We found significant
associationbetweenthedegreeofobesityandsomebiochem-
ical parameters with insulin resistance, but different levels of
25 hydroxyvitamin D status among obese children were not
an independent predictor of insulin resistance.
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